Interview with prof. Luboš Petruželka

Research — 03.10.2018

Molecular Therapy of Cancer

Interview with prof. Luboš Petruželka

Prof. Luboš Petruželka is in charge of clinical trials of new anti-cancer drug MitoTam, that was developed in the laboratories of Institute of Biotechnology CAS (BIOCEV)

Interview is available only in Czech - HERE

Official press release about the MitoTam is HERE

News

Horizontal mitochondrial transfer: New field of cell biology

Horizontal mitochondrial transfer: New field of cell biology

First International Conference on Horizontal Mitochondrial Transfer and Dynamics

First International Conference on Horizontal Mitochondrial Transfer and Dynamics

New opportunities for studying spatial proteomics at the BIOCEV Centre

New opportunities for studying spatial proteomics at the BIOCEV Centre

New results concerning a key complex regulating the Krebs cycle and oxidative phosphorylation

New results concerning a key complex regulating the Krebs cycle and oxidative phosphorylation

Kateřina Rohlenová won the Neuron 2023 Prize for research on tumor cell communication

Kateřina Rohlenová won the Neuron 2023 Prize for research on tumor cell communication

Visit of Nobel Prize winner Professor Gregg L. Semenza to BIOCEV

Visit of Nobel Prize winner Professor Gregg L. Semenza to BIOCEV

Hundreds of Diseases, One Goal

Hundreds of Diseases, One Goal

Minister Helena Langšádlová visited BIOCEV

Minister Helena Langšádlová visited BIOCEV

Members of the Scientific Advisory Board of the IBT CAS met to evaluate the activities and possibilities of further development

Members of the Scientific Advisory Board of the IBT CAS met to evaluate the activities and possibilities of further development

Czech anticancer agent works on type 2 diabetes

Czech anticancer agent works on type 2 diabetes

A new treatment strategy for kidney cancer

A new treatment strategy for kidney cancer

Professor Jiří Neužil received the Award of the Governor of the Central Bohemia Region

Professor Jiří Neužil received the Award of the Governor of the Central Bohemia Region

Pathogenic variation in the SUCLG2 gene increases the risk of rare neuroendocrine tumours

Pathogenic variation in the SUCLG2 gene increases the risk of rare neuroendocrine tumours

The Governor of the Central Bohemia Region visited the BIOCEV research centre

The Governor of the Central Bohemia Region visited the BIOCEV research centre

Platelets Facilitate the Wound-Healing Capability of Mesenchymal Stem Cells by Mitochondrial Transfer and Metabolic Reprogrammin

Platelets Facilitate the Wound-Healing Capability of Mesenchymal Stem Cells by Mitochondrial Transfer and Metabolic Reprogrammin

Targeting mitochondrial iron metabolism as a new anti-cancer strategy

Targeting mitochondrial iron metabolism as a new anti-cancer strategy

Researchers from IBT and IEM CAS have received the prestigious EXPRO 2021 grant

Researchers from IBT and IEM CAS have received the prestigious EXPRO 2021 grant

BIOCEV awarded for a significant achievement in the field of investment

BIOCEV awarded for a significant achievement in the field of investment

Vitamin C shows promise for the treatment of rare cancers

Vitamin C shows promise for the treatment of rare cancers

BIOCEV will host the 6th Biannual Meeting on Mitochondria, Apoptosis & Cancer

BIOCEV will host the 6th Biannual Meeting on Mitochondria, Apoptosis & Cancer

BIOCEV in media: How Czech billionaires invest in cancer research

BIOCEV in media: How Czech billionaires invest in cancer research

The New Role of Mitochondria in Cancer Growth

The New Role of Mitochondria in Cancer Growth

Interview with prof. Luboš Petruželka

Interview with prof. Luboš Petruželka

A new substance called MitoTam successfully disrupts breast cancer cells

A new substance called MitoTam successfully disrupts breast cancer cells

A new agent that treats more than just breast cancer has been permitted for human testing. The information was confirmed by the

A new agent that treats more than just breast cancer has been permitted for human testing. The information was confirmed by the

BIOCEV Researchers Have Forced Cancer Cells to Self-Destruct

BIOCEV Researchers Have Forced Cancer Cells to Self-Destruct